Related Experiment Video
Updated: Oct 26, 2025

A Semi-Automated and Reproducible Biological-Based Method to Quantify Calcium Deposition In Vitro
Published on: June 2, 2022
Valvular Calcific Deposits and Mortality in Peritoneal Dialysis Patients: A Propensity Score-Matched Cohort Analysis
Aiwen Shen1, Linsen Jiang2, Yunhuan Tian3
1Department of Nephrology, Second Affiliated Hospital of Soochow University, Suzhou, China, shenaiwensaw@163.com.
Insights
Cardiac valve calcification (CVC) is an independent risk factor for mortality in peritoneal dialysis (PD) patients. This study found CVC significantly increases mortality risk in PD patients, highlighting the need for closer monitoring.
Area of Science:
- Nephrology
- Cardiology
- Public Health
Background:
- Cardiovascular complications are a leading cause of mortality in patients undergoing peritoneal dialysis (PD).
- Cardiac valve calcification (CVC) is a common comorbidity in end-stage renal disease patients, but its impact on PD patient outcomes is not fully understood.
Purpose of the Study:
- To investigate the association between cardiac valve calcification (CVC) and all-cause mortality in patients undergoing peritoneal dialysis (PD).
- To identify CVC as an independent risk factor for mortality in the PD population.
Main Methods:
- A retrospective cohort study included 310 PD patients (2009-2016) with follow-up until 2018.
- Patients were categorized into groups with and without CVC (including aortic valve calcification and mitral valve calcification).
- A Fine-Gray proportional hazards model was used to analyze mortality differences after propensity score matching.
Main Results:
- Of 310 patients, 73 had CVC. After matching, 68 pairs were analyzed.
- Age and CVC were identified as independent risk factors for mortality.
- The CVC group showed a significantly higher mortality risk (HR: 1.83, p < 0.05).
Conclusions:
- Cardiac valve calcification (CVC) is an independent risk factor associated with increased mortality in peritoneal dialysis (PD) patients.
- These findings underscore the importance of assessing and managing CVC in PD patients to improve survival outcomes.
Objective:
This study aimed to compare mortality between peritoneal dialysis (PD) patients with and without cardiac valve calcification (CVC).
Methods:
Patients undergoing PD at the dialysis center of the Second Affiliated Hospital of Soochow University from January 1, 2009, to June 31, 2016, were included and followed through December 31, 2018. The inclusion criteria were (1) age ≥18 years and (2) PD vintage ≥1 month. The exclusion criteria were (1) a history of hemodialysis or renal transplantation before PD; (2) diagnosed congenital heart disease, rheumatic heart disease, or hyperthyroid heart disease; and (3) loss to follow-up. Differences in mortality rates were compared using a Fine-Gray proportional hazards model.
Results:
A total of 310 patient cases were included in this study, including 237 cases without CVC (non-CVC group). The CVC group included 59 cases with aortic valve calcification (AVC), 6 cases with mitral valve calcification (MVC), and 8 cases of AVC associated with MVC. After propensity score matching, 68 pairs were selected. The multivariate competing risk regression analysis revealed that age (hazard ratio [HR]: 1.06, 95% confidence interval [95% CI]: 1.03-1.10, p < 0.001) and CVC group (HR: 1.83, 95% CI: 1.04-3.20, p < 0.05) were independent risk factors associated with mortality. No significant difference was observed in technique survival between the 2 groups.
Conclusion:
CVC is an independent risk factor for mortality in PD patients.
More Related Videos
Related Concept Videos
Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications
Peritoneal Dialysis III: Nursing Management
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
Hemodialysis II: Procedure and Complications
Peritoneal Dialysis I: Introduction and Procedure
Extracorporeal Removal of Drugs: Peritoneal Dialysis and Hemodialysis

